Coronary Undivided
Payments companies reported to CMS as associated with Coronary Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Coronary Undivided, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Coronary Undivided
These are the largest totals companies reported as associated with Coronary Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Antonis Pratsos | Broomall, PA | Interventional Cardiology | $8,800.00 |
| Jimmy Kerrigan | Nashville, TN | Interventional Cardiology | $5,752.28 |
| Santosh Desai | Mesa, AZ | Cardiovascular Disease | $5,640.00 |
| George Chrysant | Oklahoma City, OK | Interventional Cardiology | $2,729.62 |
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $2,138.91 |
| Karim Al-Azizi | Plano, TX | Interventional Cardiology | $1,380.26 |
| Asseel Albayati | Fresno, CA | Internal Medicine | $839.33 |
| Irfan Siddiqui | Newburgh, IN | Interventional Cardiology | $826.47 |
| Adeel Siddiqui | Evansville, IN | Interventional Cardiology | $826.47 |
| Robert Widmer | Temple, TX | Interventional Cardiology | $733.18 |
Prescribed Coronary Undivided?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.